We found that CXCL11 was mostly significantly decreased in tumor tissues, and identified nine patients with increased CXCL11 expression in tumor tissues compared to adjacent normal tissue samples (Fig. 2a, b). This evidence concerns the gene CXCL11 and neoplasm.